3rd ESOP‐ESO ADVANCED MASTERCLASS IN ONCOLOGY PHARMACY  22‐26 May 2017, Lisbon, Portugal   

 APPLICATION FORM (deadline: 28 February 2017)  Documents to be submitted with the application form at the application deadline:  ‐   Letter describing motivation for attending  ‐   Curriculum vitae with list of publications (if the list of publications is not provided, 

it will be assumed that no articles have been published)  ‐   Certificates of attendance of the basic and intermediate masterclass in oncology 

pharmacy or equivalent (eg. BCOP, DGOP Weiterbildung Onkologische Pharmazie)  ‐   Proof of at least 2 years’ experience in oncology pharmacy (job reference)  ‐   Description of 2 cases of your own practice in oncology pharmacy (abstracts, see 

page 3)  

  Please save this file, complete it with your contact and professional details, your abstracts and return it with required documents to the ESOP Membership Service  – membershipservice@esop.li  The application form should be submitted as a Word file and electronically only. The acknowledgement of receipt will be sent within 72 hours.    Your details:  

Family name   

First name   

Date of birth   

Gender   

   

Institute   

Department   

Address   

Zip code   

Town   

Country   

Phone number   

Fax number   

Cell number   

e‐mail (*)   

 *All correspondence regarding your application will be sent by email  

Please describe here your experience in clinical oncology pharmacy:  

Year / period  Description 

   

   

   

   

   

   Please describe here your involvement in scientific activities and/or clinical trials:  

Year / period  Description 

   

   

   

   

   

   How would you divide the percentage of your daily work that you are involved in oncology pharmacy:  

  % 

  How would you rate your English, from 1 (basic) to 5 (mother tongue)?  

Rate   

 

REGISTRATION fee The organization of the ESOP‐ESO Advanced Masterclass in Oncology Pharmacy is supported by grants provided jointly by the European Society of Oncology Pharmacy and the European School of Oncology. The participation fee represents a contribution to the costs related to the participant’s attendance.  Please be informed that admitted participants will contribute to their participation’s costs as follows: Please tick the appropriate box to indicate your registration type:  □ ESOP Member EUR 600 □ ESOP Non‐Member EUR 790 

 PAYMENT DETAILS  Please note that payments should be made to:  

Bank transfer to the ESOP bank account: ESOP, 9, rue Edward Steichen, L‐ 2540 LUXEMBOURG:  BGL BNP Paribas, 10, rue E. Steichen, L‐2951 LUXEMBOURG  BIC: BGLLLULLBIC: DAAEDEDD, IBAN: LU33 0030 3596 5023 3000  Payment Details: ESOP /Invoice Number/ Name and Surname of Participant for whom payment is made  • Bank charges are fully covered by participants   Payment of the fee will be requested upon notification of the application’s acceptance.  The registration fee included the participation at the scientific program, catering and the networking evening. Travel and accommodation expenses shall be covered by participants. Application is only possible with concurrent payment of the registration fee 

 Please insert your abstracts in the table below. It is important that the abstracts are submitted as a Word file and sent by e‐mail.  The abstract: 

‐ Should describe a clinical case relating to one of the subjects of the Masterclass, (format: example see at http://www.esop.eu/casereports.php. 

‐ Should not report trials or research projects. ‐ Should include three questions relating to the clinical case that the applicant puts to the faculty for 

discussion.   

Abstract 1 

Subject   

Title   

Author   

Introduction   

Diagnostic considerations 

 

Treatment   

Results / Follow‐up 

 

Question 1   

Question 2   

Question 3   

  

Abstract 2 

Subject   

Title   

Author   

Introduction   

Diagnostic considerations 

 

Treatment   

Results / Follow‐up 

 

Question 1   

Question 2   

Question 3   

  

ESO EDUCATION 2016-2017 | 21

Learning objectives:• Improve expertise to actively participate with the medical team

to the initial management of a cancer patient • Improve skills to inform the medical and nursing team on all

relevant information about new anticancer treatments, their administration and side-effects

• Learn how to manage potential side-effects of the treatment bythe definition of an appropriate prevention plan and their follow-up

• Improve skills in establishing appropriate informative plans ontreatments for patients and their relatives

Main topics:• Clinical cases covering the majority of the diseases and

pharmaceutical cases that can occur in the clinical setting• The hematopoietic stem cell transplant patient and other

complex situations• Toxicities and symptom management• Drug interactions of anticancer agents• Oncological emergencies• Patient counseling• Clinical trials• Research• Collective prescription process• Drug and therapeutic committee• Pharmaco-economics

Participant’s profile:• Cancer service pharmacists• Professional experience in oncology• Involvement in scientific activities (desirable)• Fluency in English

Further information:ESOP Membershipservice - c/o DGOP e.VHamburg, GermanyPetra Janssen, membershipservice@esop.li, ph +49 40 466500300

The Advanced Masterclass will be mainly based on clinicalcases covering the majority of diseases and pharmaceuti-cal cases which can occur in the clinical setting. Some

cases will be focused on less common cancer entities such ashaematological malignancies, paediatric cancer, cancer of geri-atric patients, treatment of patients with organ dysfunctions(renal, liver, cardiac, etc.) and rare cancers.The hematopoietic stem cell transplant patients shall be alsocovered. Clinical cases should familiarise the oncology pharmacist to complex situations where pharmaceutical

expertise is required to improve the treatment (toxicities andtheir management, symptom management, drug interactions ofanticancer agents, management of side-effects, etc.), oncological emergencies and patient counseling. Current practice, recent advances and emerging therapies aswell as case studies highlighting pertinent issues shall be introduced. Pharmaceutical situation shall also refer to the content of prior levels like problems concerning drug stability,physico-chemical compatibility and their possible effects on thepatient’s therapy.

3RD ESOP-ESO ADVANCED MASTERCLASS IN ONCOLOGY PHARMACY

DEADLINEBy APPLICATION ONLy: 28 FEBRUARy 2017

22 -26 May 2017 - Lisbon, Portugal Chairs: A. Astier, FR - M. Daouphars, FR - N. Vilaca Marques, PT - G. Wiedemann, DE - K. Meier, DE

ESO_EDU_interniOK.qxp_Layout 1 23/09/16 17:19 Pagina 21